Christopher E. Touloukian
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 16
- Immunotherapy and Immune Responses 16
- T-cell and B-cell Immunology 12
- Immune Cell Function and Interaction 5
-
- vaccines and immunoinformatics approaches 6
- Ubiquitin and proteasome pathways 1
- Co-authors
- Nicholas P. Restifo (15 shared papers)Steven A. Rosenberg (9 shared papers)Kari R. Irvine (3 shared papers)Lionel Feigenbaum (3 shared papers)Deborah R. Surman (4 shared papers)Paul A. Antony (2 shared papers)Douglas C. Palmer (2 shared papers)Chi‐Chao Chan (1 shared paper)
- Journals
- The Journal of Immunology (3 papers)Journal of Clinical Investigation (3 papers)Journal of Immunotherapy (2 papers)Blood (1 paper)Carcinogenesis (1 paper)
- Partner nations
- United StatesNetherlandsAustralia
In The Last Decade
Christopher E. Touloukian
22 papers receiving 1.8k citations
Christopher E. Touloukian's Hit Papers
Peers
Comparison fields: 5 of 79
- Immunology 1.5k
- Oncology 818
- Molecular Biology 524
- Biotechnology 52
- Genetics 150
Countries citing papers authored by Christopher E. Touloukian
This map shows the geographic impact of Christopher E. Touloukian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Touloukian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Touloukian more than expected).
Fields of papers citing papers by Christopher E. Touloukian
This network shows the impact of papers produced by Christopher E. Touloukian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Touloukian. The network helps show where Christopher E. Touloukian may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher E. Touloukian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-specific Th17-polarized cells eradicate large established melanoma Hit paper breakdown → | 2008 | 664 |
| 2 | 1999 | 332 | |
| 3 | 2000 | 127 | |
| 4 | 2000 | 113 | |
| 5 | 2004 | 105 | |
| 6 | 2004 | 104 | |
| 7 | 2003 | 93 | |
| 8 | 2012 | 52 | |
| 9 | 2014 | 38 | |
| 10 | Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens. | 1999 | 36 |
| 11 | 2002 | 26 | |
| 12 | 2002 | 24 | |
| 13 | Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function. | 2002 | 23 |
| 14 | 2003 | 21 | |
| 15 | 2010 | 18 | |
| 16 | Mining the melanosome for tumor vaccine targets: P.polypeptide is a novel tumor-associated antigen. | 2001 | 18 |
| 17 | 2009 | 16 | |
| 18 | 1996 | 11 | |
| 19 | 2013 | 6 | |
| 20 | A survey of treatments used in patients with metastatic melanoma: analysis of 189 patients referred to the National Cancer Institute. | 2000 | 4 |
About Christopher E. Touloukian
Christopher E. Touloukian is a scholar working on Immunology, Molecular Biology, Oncology, Epidemiology and Surgery, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (16 papers), T-cell and B-cell Immunology (12 papers), vaccines and immunoinformatics approaches (6 papers), Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Immunology (1.5k citations), Oncology (818 citations), Molecular Biology (524 citations), Biotechnology (52 citations) and Genetics (150 citations). Christopher E. Touloukian has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include Nicholas P. Restifo, Steven A. Rosenberg, Kari R. Irvine, Lionel Feigenbaum, Deborah R. Surman, Paul A. Antony, Douglas C. Palmer, Chi‐Chao Chan, Andrea Boni and Lydie Cassard. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Investigation, Journal of Immunotherapy, Blood and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.